• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Reglan (metoclopramide) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- September 2009

 

Summary View

 

REMS

The goal of this REMS is to minimize the risk of tardive dyskinesia associated with the longterm use of Reglan tablets.

MEDICATION GUIDE

A Medication Guide will be dispensed with each Reglan tablet prescription.